Cargando…
497. Moderate Versus High Dose Corticosteroids in Adult Patients with Severe COVID-19: Less Is More
BACKGROUND: The early administration of corticosteroids (CS) in patients with severe COVID-19 (hospitalized with need for supplemental oxygen) has been the only therapy to improve survival. However, the optimal dosing of CS remains unclear. Beginning March 2020 methylprednisolone (MP) in a dose of 4...
Autores principales: | Joshi, Seema, Soman, Sana, Jain, Saniya, Yako, Atheel, Hojeij, Marwa, Massoud, Louis, Alsaadi, Ayman, Smith, Zachary R, Alangaden, George J, Kenney, Rachel, Mayur, Ramesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644057/ http://dx.doi.org/10.1093/ofid/ofab466.696 |
Ejemplares similares
-
Low- Versus High-Dose Methylprednisolone in Adult Patients With Coronavirus Disease 2019: Less Is More
por: Joshi, Seema, et al.
Publicado: (2021) -
Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19
por: Fadel, Raef, et al.
Publicado: (2020) -
Real-world Experience of Sotrovimab in High-risk, Immunocompromised COVID-19 Patients
por: Birk, Navina K, et al.
Publicado: (2022) -
505. Bezlotoxumab Reduces Recurrence of Clostridium difficile Infection in Immunocompromised Patients: Early Experience at a Tertiary Care Center
por: Askar, Sally, et al.
Publicado: (2018) -
607. Candidemia: Role of T2Candida® compared to Bact/Alert Virtuo blood culture system in a real-world setting
por: Birk, Navina K, et al.
Publicado: (2023)